Climb Up has obtained a capital increase subscribed by Calcium Capital
Climb Up has obtained a capital increase subscribed by Calcium Capital. The equity raised will be used to develop new halls and acquire new ones.
Climb Up is the French leader in operating climbing halls. It was founded in 2011 by François Petit, a former indoor climbing world champion. The company offers a full customer experience with climbing lanes, blocks, children's area, a restaurant and various relaxing areas.
Calcium Capital is a French private equity and venture capital firm specializing in late-stage venture, middle-market, mature, buy-outs, emerging growth, industry consolidation and growth capital investments.
Oaklins' team in France advised Climb Up in this transaction. The team organized a growth equity transaction of US$15 million to support the company's growth.
Talk to the deal team
Managing PartnerParis, France
Antoine de Bardies
OFFIX Holding and Office World Holding bundled their activities into the newly formed JV Office World Group
OFFIX Holding AG and Office World Holding AG have bundled their businesses into the newly founded Office World Group AG. Office World Holding brings its subsidiaries Office World, iba and Tramondi, and OFFIX brings its companies Papedis, Ecomedia, Oridis, Office Leader and DocuServ into the new Office World Group AG. The merger creates a Swiss group that will be represented throughout the country, generating sales of approximately US$400 million with just under 600 employees.Learn more
CAPZA and RAISE Impact have invested in Oui Care to accelerate its internal and external growth strategies
The shareholders and management of Oui Care have raised funds and restructured its debt for up to US$78.5 million (US$42.2 million for external growth and US$36.3 million in refinancing). This investment will support Oui Care and its management in this new stage of development.Learn more
Hardford has sold its wholly owned subsidiary Hardford Brands to Pharmaxim
Hardford Holding AB has sold Hardford Brands AB to Pharmaxim AB.Learn more